Analystreport

Applied Genetic Technologies Corp (NASDAQ: AGTC) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.50 price target on the stock.

Applied Genetic Technologies Corporation  (AGTC) 
Last applied genetic technologies corporation earnings: 2/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agtc.com/investor-relations